Antizyme Inhibitor 1 Regulates Matrikine Expression and Enhances the Metastatic Potential of Aggressive Primary Prostate Cancer.
Thomas Van den BroeckLisa MorisThomas GevaertElai DavicioniBram BoeckxDiether LambrechtsChristine HelsenFlorian HandleBart GhesquiereStefaan SoenenElien SmeetsRoy EerlingsSarah El KharrazWout DevliesR Jeffrey KarnesTamara LotanHendrik Van PoppelSteven JoniauFrank ClaessensPublished in: Molecular cancer research : MCR (2022)
AZIN1 was identified as driver of metastatic progression in high-risk prostate cancer through matrikine regulation.